How breast cancer cells avoid cell death

How breast cancer cells avoid cell death

Two new papers from the lab of Zach Schafer, Coleman Assistant Professor of Cancer Biology at the University of Notre Dame, offer insights into how breast cancer cells avoid anoikis, which is cell death induced by detachment from the extracellular matrix (ECM).

"Metastasis, the spread of cancer cells from the site to distant sites in the body, is responsible for in excess of 90 percent of cancer deaths," Schafer said. "In order for cancer cells to metastasize, they must survive the trip from the primary tumor to a secondary site. A significant barrier to cancer cell survival is the process of anoikis. Cancer cells are periodically exposed to ECM detachment during metastasis, and thus it is critically important to better understand at the molecular level how cancer cells block anoikis. If we could better understand these molecular mechanisms, we could design novel chemotherapeutics aimed at inducing anoikis and thereby blocking metastasis."

The research described in the first paper describes how Schafer's lab group discovered that ErbB2, an oncogene overexpressed in approximately 30 percent of breast cancer patients, can block the induction of anoikis by causing multicellular aggregation. This multicellular aggregation results in stabilization of another protein, EGFR, that can signal in ECM-detached breast cancer cells to block anoikis.

"These findings suggest that finding ways to break up multicellular aggregates might be an effective strategy to eliminate metastasizing ," Schafer said. "In addition, targeting the EGFR protein has not been particularly effective in , but our studies suggest that this may be a useful strategy to eliminate ECM-detached cancer cells."

The research was led by Raju Rayavarapu, a doctoral candidate in the Department of Biological Sciences under Schafer's supervision. Melissa Shaw, a junior major, was a contributing author, and two former Notre Dame undergraduates, Brendan Heiden and Nicholas Pagani, also were co-authors. Additionally, Sydney Shuff, a high school senior at Concord High School in Elkhart, was a co-author and Siyuan Zhang, Nancy Dee Assistant Professor of Cancer Research at the Harper Cancer Research Institute, collaborated on the work.

The paper was featured as the cover article of the Journal of Biological Chemistry and can be accessed here. Kimbra Turner, a doctoral student in biological sciences at Notre Dame, designed the cover art.

The second paper focused on understanding anoikis inhibition in , a rare subtype of breast cancer.

"Inflammatory (IBC) has a very unique disease progression that causes women to be frequently misdiagnosed," Schafer said. "Instead of starting as a lump in the breast, IBC manifests as reddened skin that is often mistaken for an infection. In fact, this reddening is due to IBC cancer cells lodging in the lymphatic vessels under the skin. It is inherently aggressive and the fact that it is frequently misdiagnosed exacerbates problems for the patient. Prognosis for women with IBC is often poor."

In this study, the researchers discovered a unique molecular mechanism used by IBC cells to block anoikis.

"Unlike what we observed in other breast , we have found that IBC cells have elevated levels of the protein Bim-EL," Schafer said. "This protein typically would either be eliminated rapidly or, conversely, localized in the cell to cause cell death. However, in IBC cells, this protein binds to two other proteins (Beclin-1 and LC8) in a fashion that prevents it from causing . This appears to be a unique mechanism utilized by IBC cells to block anoikis."

The fact that Bim-EL, a protein that can cause cells to die, is present in high levels in IBC cells represents an attractive therapeutic target. Approaches aimed at freeing Bim-EL from the complex with Beclin-1 and LC8 may be effective in specifically eliminating IBC cells.

The paper appeared in the journal Cell Death and Differentiation.

More information: "The Role of Multicellular Aggregation in the Survival of ErbB2-positive Breast Cancer Cells during Extracellular Matrix Detachment" J. Biol. Chem. 2015 290: 8722-8733. First Published on February 13, 2015, DOI: 10.1074/jbc.M114.612754

"Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration" Cell Death and Differentiation advance online publication 19 December 2014; DOI: 10.1038/cdd.2014.209

Journal information: Journal of Biological Chemistry

Citation: How breast cancer cells avoid cell death (2015, April 20) retrieved 1 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New paper offers insights into how cancer cells avoid cell death


Feedback to editors